Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II.
The aim of the present study is primarily to re-examine an animal model of acute myocardial infarction (AMI) and arterial thrombosis, developed by Constantinides and his colleagues in the 1960s, in both heritable hyperlipidemic rabbits and normal rabbits because they did not study these rabbits. The groups in this study consisted of 29 normal rabbits and 29 Watanabe heritable hyperlipidemic (WHHL) rabbits. These rabbits were administered Russell's viper venom (RVV) as a procoagulant, intraperitoneally with serotonin or angiotensin II or saline, intravenously. As a control, 10 normal and 17 WHHL rabbits were administered intravenously with either angiotensin II or saline. These treatments were given on 2 successive days. AMI lesion was found in 8 of 29 normal and 7 of 29 WHHL rabbits receiving RVV and angiotensin or serotonin. Angiotensin II promoted the incidence of aortic thrombosis associated with segmental medial necrosis and an intimal disruption in WHHL rabbits receiving RVV. In the normal rabbits, angiotensin II in addition to RVV induced segmental medial necrosis of the aorta, but angiotensin II alone did not. Thus, we postulated that a synergistic effect of RVV as a cytotoxic substance and a sudden increase in the aortic wall tension by angiotensin II might thus result in acute aortic medial necrosis. The conclusion was that no close correlation between coronary arteriosclerosis and AMI was found in this animal model. The intravenous administration of angiotensin promoted aortic medial necrosis even in normal rabbits treated with RVV and then accelerated aortic thrombosis in the WHHL rabbits treated with RVV.
Nakamura
M
M
The Graduate School of Health and Nutrition Sciences, Nakamura-Gakuen University, Fukuoka, Japan.
Abe
S
S
Kinukawa
N
N
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000473:pathology*; D001018:Aortic Diseases / Q000139:chemically induced* / Q000473:pathology; D001794:Blood Pressure / Q000187:drug effects; D004357:Drug Synergism; D005260:Female; D006949:Hyperlipidemias / Q000235:genetics; D008297:Male; D009203:Myocardial Infarction / Q000209:etiology; D009336:Necrosis; D011817:Rabbits / Q000235:genetics; D012016:Reference Values; D017840:Daboia; D012701:Serotonin / Q000494:pharmacology; D013927:Thrombosis / Q000139:chemically induced* / Q000473:pathology; D017540:Tunica Media / Q000473:pathology*; D014757:Viper Venoms
D014757:Viper Venoms; D000804:Angiotensin II; D012701:Serotonin